CTX321 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

61 results for “CTX321”

Trials

View all 48 →

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

90 participants · First posted Mar 24, 2026

A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.

106 participants · First posted Jun 5, 2026

XTX301 in Patients With Advanced Solid Tumors

358 participants · First posted Jan 13, 2023

Drugs

CTH121/CTH221

CMX521

CTH121

News

CRISPR Therapeutics' CTX310 Shows Promising Lipid Reduction Results in Phase 1 Trial

CTx001 Gene Therapy Shows Early Tolerability and Slowed Lesion Progression in Geographic Atrophy

CRISPR Therapeutics' CTX112 Shows Promise in B-Cell Malignancies, Receives FDA RMAT Designation

Page 1 of 7